COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Evaluation of Schemes of Administration of Intravenous Ketamine in Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03742557
Recruitment Status : Recruiting
First Posted : November 15, 2018
Last Update Posted : September 10, 2019
Information provided by (Responsible Party):
Rodrigo Pérez Esparza, National Institute of Neurology and Neurosurgery, Mexico

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 1, 2020
Estimated Study Completion Date : January 1, 2020
Publications of Results:
Espinosa-Aguilar C-A, Zamora-Olvera, Arronte-Rosales, Krug-Llamas, Olivares-Santos, Reyes-Morales, Tapia-Garcia, Garcia-Gonzalez, Doubova. Guía de práctica clínica para el diagnóstico y tratamiento de depresión en los adultos mayores. Salud Mental. 2007;30(6):69-80.
Heinze C. Guía clínica para el Manejo de la Depresión. In: Psiquiatría INd, ed. Guías Clínicas para la Atención de Trastornos Mentales. Mexico D.F.2010.

Other Publications:
American Psychiatric Association., American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders : DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
Pérez-Esparza R. Tratamiento farmacológico de la depresión: actualidades y futuras direcciones. Revista de la Facultad de Medicina. 2017;60(5):7-16.